| Literature DB >> 34940519 |
Eleftherios Karatzanos1, Panagiotis Ferentinos2, Georgios Mitsiou1, Stavros Dimopoulos1, Argyrios Ntalianis3, Serafeim Nanas1.
Abstract
The purpose of this study was to compare the acute cardiorespiratory responses and time spent above different %VO2peak intensities between three "iso-work" protocols: (a) a high intensity interval training protocol (HIIT), (b) a higher intensity continuous protocol (CON70) and (c) a lower intensity continuous protocol (CON50) in patients with chronic heart failure (CHF). Ten male CHF patients (aged 55.1 ± 16.2 years) performed in separate days a single session of a HIIT protocol consisted of 4 sets × 4 min cycling at 80% VO2peak with 3 min of recovery at 50% VO2peak, a CON70 protocol corresponding to 70% VO2peak and a CON50 protocol corresponding to 50% VO2peak. Cardiopulmonary data were collected by an online gas analysis system. The HIIT and CON70 elicited higher cardiorespiratory responses compared to CON50 with no differences between them (p > 0.05). In HIIT and CON70, patients exercised longer at >80% and >90% VO2peak. The completion rate was 100% for the three protocols. Not any adverse events were observed in either protocol. Both HIIT and CON70 elicited a stronger physiological stimulus and required shorter time than CON50. Both HIIT and CON70 also induced comparable hemodynamic responses and ventilatory demand.Entities:
Keywords: acute exercise; cardiac rehabilitation; continuous exercise; heart failure; high intensity interval training
Year: 2021 PMID: 34940519 PMCID: PMC8708548 DOI: 10.3390/jcdd8120164
Source DB: PubMed Journal: J Cardiovasc Dev Dis ISSN: 2308-3425
Anthropometric, clinical and cardiopulmonary exercise testing characteristics.
| ( | Values a |
|---|---|
| Age (Years) | 55.1 ± 16.2 |
| Men | 10 (100%) |
| Weight (kg) | 84.9 ± 21.4 |
| Body mass index (kg/m2) | 27.9 ± 4.7 |
| Height (cm) | 172.9 ± 9.4 |
| VO2peak (mL∙kg−1∙min−1) | 19.8 ± 4.5 |
| VO2peak (% VO2peak predicted) | 65.7 ± 10.1 |
| AT (mL∙kg−1∙min−1) | 12.3 ± 3.2 |
| AT (% VO2peak) | 62 ± 7 |
| HRpeak (beats·min−1) | 122 ± 14 |
| NYHA classification I/II/III, | 2 (20%)/7 (70%)/1 (10%) |
| LVEF | 33.8 ± 5.3 |
| Etiology of heart failure | |
| Dilated cardiomyopathy | 3 (30%) |
| Ischemic heart disease | 6 (60%) |
| Valvular | 1 (10%) |
| Medications | |
| ACE inhibitors | 8 (80%) |
| β-blockers | 8 (80%) |
| Loop diuretics | 10 (100%) |
| Antiplatelets/Anticoagulants | 6 (60%)/1 (10%) |
| Spironolactone | 4 (40%) |
| Nitrates | 2 (20%) |
| Amiodarone | 2 (20%) |
| ICD device | 2 (20%) |
Abbreviations: ACE, angiotensin converting enzyme; ARBs, angiotensin receptor blockers; AT, anaerobic threshold; HRpeak, heart rate peak; ICD, implantable cardioverter defibrillator; LVEF, left ventricular ejection fraction; NYHA, New York Heart Association; VO2peak, peak oxygen consumption. a Data presented as mean ± SD or n (%).
Cardiorespiratory responses during HIIT, CON70 and CON50.
| HIIT | CON70 | CON50 | Partial η2 | Observed Power | ||
|---|---|---|---|---|---|---|
| VO2 sum (L) | 38.7 ± 11.1 | 36.2 ± 10.4 a | 53.5 ± 10.2 a,b | <0.001 | 0.915 | 1.000 |
| VE sum (L) | 1274.1 ± 280.6 | 1155.3 ± 263 a | 1574 ± 241.5 a,b | <0.001 | 0.795 | 1.000 |
| VE (L∙min−1) | 41.1 ± 2.8 | 42.0 ± 2.8 | 27.8 ± 1.5 a,b | <0.001 | 0.901 | 1.000 |
| VO2 (mL∙kg−1∙min−1) | 14.9 ± 3.3 | 15.7 ± 3.1 | 11.5 ± 2.1 a,b | <0.001 | 0.899 | 1.000 |
| VO2 (% VO2peak) | 75.9 ± 6.4 | 79.8 ± 5.9 a | 58.8 ± 4.9 a,b | <0.001 | 0.960 | 1.000 |
| VE/VCO2 | 34.8 ± 3.9 | 34.5 ± 4.4 | 34.1 ± 4.2 | 0.755 | 0.031 | 0.084 |
| RER | 0.95 ± 0.04 | 0.94 ± 0.06 | 0.87± 0.04 a | 0.002 | 0.486 | 0.934 |
| O2 pulse (mL∙beat−1) | 13.6 ± 3.1 | 14.0 ± 2.5 | 11.9 ± 2.2 a,b | 0.002 | 0.599 | 0.948 |
| Heart rate (beats∙min−1) | 91.3 ± 12.6 | 93.4 ± 13.9 | 80.6 ± 11.7 a,b | <0.001 | 0.716 | 1.000 |
| Heart rate peak (%) | 74.7 ± 8.8 | 76.8 ± 11.4 | 67.3 ± 9.2 a,b | 0.001 | 0.518 | 0.959 |
Abbreviations: O2 pulse; oxygen pulse, RER; respiratory exchange ratio, VE; minute ventilation, VE sum, total ventilation, VE/VCO2; ventilatory equivalent for carbon dioxide; VO2 sum; total oxygen uptake; VO2; oxygen uptake. Data reported as mean ± SD or n (%). a Significant compared to HIIT (p < 0.05). b Significant compared to CON70 (p < 0.01).
Time (min) spent > AT, >70%, >80% and >90% VO2peak.
| HIIT | CON70 | CON50 | partial η2 | Observed Power | ||
|---|---|---|---|---|---|---|
| >AT | 23.8 ± 6.1 | 25.0 ± 3.7 | 24.2 ± 21.2 | 0.962 | 0.040 | 0.055 |
| >70% VO2peak | 19.3 ± 3.8 | 24.6 ± 2.9 a | 3.1 ± 5.4 a,b | <0.001 | 0.930 | 1.000 |
| >80% VO2peak | 13.7 ± 5.0 | 15.5 ± 10.3 | 0.2 ± 0.7 a,b | <0.001 | 0.723 | 1.000 |
| >90% VO2peak | 6.3 ± 5.0 | 2.6 ± 4.9 a | 0.02 ± 0.0 a,b | 0.03 | 0.482 | 0.930 |
Abbreviations: AT; anaerobic threshold, HIIT; high intensity interval training, VO2peak; peak oxygen uptake. Data reported as mean ± SD. a Significant compared to HIIT (p < 0.01). b Significant compared to CON70 (p < 0.01).